Skip to main content

BRIEF-Eiger completes enrollment in phase 2 limt hdv study

* Eiger completes enrollment in Phase 2 LIMT HDV study of pegylated interferon lambda in Hepatitis Delta Virus infection
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.